Financhill
Back

Vera Therapeutics Quote, Financials, Valuation and Earnings

Vera Therapeutics Price Quote

$48.99
-0.41 (-0.83%)
(Updated: November 14, 2024 at 5:15 PM ET)

Vera Therapeutics Key Stats

Buy
80
Vera Therapeutics (VERA) is a Buy

Day range:
$48.59 - $51.61
52-week range:
$12.28 - $50.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
8.12%

Volume:
1M
Avg. volume:
921.4K
1-year change:
287.15%
Market cap:
$2.7B
Revenue:
$0
EPS:
$-2.21

How Much Does Vera Therapeutics Make?

Data Unavailable

Is Vera Therapeutics Growing As A Company?

Data Unavailable

Vera Therapeutics Stock Price Performance

What Is Vera Therapeutics 52-Week High & Low?

Vera Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vera Therapeutics?

  • How Much Debt Does Vera Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vera Therapeutics Have?
    Cash and short term investments quarterly total is $384.4M
  • What Is Vera Therapeutics’s Book Value Per Share?
    Book value per share is 5.98

Is Vera Therapeutics Cash Flow Positive?

  • What Is VERA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$106.7M
  • What Is Vera Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $305.1M
  • What Is Vera Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$207.2M

Vera Therapeutics Return On Invested Capital

Data Unavailable

Vera Therapeutics Earnings Date & Stock Price

Vera Therapeutics Competitors

  • Who Are Vera Therapeutics's Competitors?
    Below is a list of companies who compete with Vera Therapeutics or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • PROCEPT BioRobotics Corp (PRCT)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Vera Therapeutics Dividend Yield

Vera Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -38.73%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 63.91
Upside from Last Price: 29.37%

Major Shareholders

  • How many VERA shares are owned by institutional investors?
    76.6M VERA shares are owned by institutional investors
  • How many VERA shares are owned by insiders?
    615.9K VERA shares are owned by insiders